Xeriant, Inc.: Form 10-Q for the period ended Mar 31, 2020
Filed with the SEC on May 20, 2020 and accepted by EDGAR at May 20, 2020, 13:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 9 months2019-07-01 to 2020-03-31 | $6.3k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-01-01 to 2020-03-31 | −$121.7k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-07-01 to 2020-03-31 | −$263.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-01-01 to 2020-03-31 | −$4.5k | us-gaap:InterestExpense |
| Interest expense | 9 months2019-07-01 to 2020-03-31 | −$8.6k | us-gaap:InterestExpense |
| Net income | 3 months2020-01-01 to 2020-03-31 | −$293.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-07-01 to 2020-03-31 | −$589.2k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-01-01 to 2020-03-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2019-07-01 to 2020-03-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2019-07-01 to 2020-03-31 | −$237.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2020-03-31 | $138.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-03-31 | $150.9k | us-gaap:AssetsCurrent |
| Total assets | At period end2020-03-31 | $370.6k | us-gaap:Assets |
| Current liabilities | At period end2020-03-31 | $346.7k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-03-31 | $540.6k | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-03-31 | −$170.0k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-20-002947. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.